Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
Younger patients with COVID-19 may experience an exaggerated immune response to SARS-CoV-2 infection and develop cytokine release syndrome (CRS), which may be life threatening. There is no proven antiviral therapy for COVID-19 so far, but profound immunosuppression has recently been suggested as a t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SMC MEDIA SRL
2020-04-01
|
| Schriftenreihe: | European Journal of Case Reports in Internal Medicine |
| Schlagworte: | |
| Online-Zugang: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1675 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|